You are currently visiting a Non-US site. 
US visitors please click here >



The Resorbable Collagen Membrane

Instructions for Use for OSSIX® PLUS

pdfOSSIX PLUS IFU ver 05 English

IFU text (without icons) can be found below. Please refer to PDF above for full IFU. 


OSSIX® PLUS is a biodegradable collagen membrane, obtained by standardized and controlled manufacturing procedures.
The collagen is extracted from porcine derived tendons that are subjected to veterinarian inspection and is purified to prevent hypersensitivity reactions. OSSIX® PLUS is packaged in a sealed double blister contained in a cardboard box and
is terminally sterilized by Ethylene Oxide (EtO).
OSSIX® PLUS is packaged in a single membrane double blister pack, in which the outer blister contains a template material (not collagen) and the inner blister contains the OSSIX® PLUS membrane, for a single use.

OSSIX® PLUS has an excellent biocompatibility profile, resulting in a low potential to induce hypersensitivity.
OSSIX® PLUS has a porous structure; its pore size is occlusive for gingival cells yet permits the passage of fluids and plasma proteins, which assist in flap closure.
OSSIX® PLUS is not self-supporting and therefore it is recommended for use in conjunction with support such as an autogenous bone graft, allograft, xenograft or an osteoconductive and/or inductive bone substitute, or a mixture of these.
OSSIX® PLUS retains its structural integrity when wet.
OSSIX® PLUS conforms easily to the shape of the alveolar ridge.
An animal study has shown that OSSIX® PLUS degradation is completed within approximately 8 months.

OSSIX® PLUS biodegradable collagen membrane is intended for use during the process of guided bone regeneration (GBR) and guided tissue regeneration (GTR) as a biodegradable barrier for:
  1. Ridge augmentation for later implant insertions.
  2. Simultaneous ridge augmentation and implant insertions.
  3. Ridge augmentation around implants inserted in delayed extraction sites.
  4. Ridge augmentation around implants inserted in immediate extraction sites.
  5. Alveolar ridge preservation consequent to tooth (teeth) extraction(s).
  6. Over the window in lateral window sinus elevation procedure.
  7. In implants with vertical bone loss due to infection, only in cases where satisfactory debridement and implant surface disinfection can be achieved.
  8. In intra bony defects around teeth.
  9. For treatment of recession defects, together with coronally positioned flap.
  10. In furcation defects in multi rooted teeth.

OSSIX® PLUS must not be used in:
1. Patients with known collagen hypersensitivity.
2. Patients with sensitivity to porcine-derived materials.
3. Patients suffering from autoimmune disease and connective tissue disease, such as: systemic lupuserythematosous, dermatomyositis etc.

1. OSSIX® PLUS is intended for a single use device (membrane and template). Do not re-sterilize OSSIX® PLUS.
2. Treatment of high risk patients, such as: smokers, patients suffering from uncontrolled diabetes mellitus, and uncontrolled periodontal disease may be impaired.
3. The safety of treatment with OSSIX® PLUS in pregnant and nursing women and in children has not been yet established.
4. The outcome of regenerative procedures may be impaired in patients suffering from untreated periodontitis. Infection control and good oral hygiene should be achieved prior to surgical intervention.

1. Clinical and post marketing experience with Ossix™, the bovine counterpart, reveals an excellent safety profile during long term experience.
2. Adverse reactions with a porcine collagen membrane were not observed.
3. Yet, as the membrane is of a collagen origin, allergic reactions (e.g. erythema, swelling, induration and/or pruritus at treatment site) may not be entirely excluded.


1. The bony defect should be exposed by full thickness muccoperiosteal flaps.
2. All soft tissues should be removed.
3. In GTR the root surface should be carefully debrided and planed. Root conditioning should be considered.
4. The cortical plate can be perforated in order to allow osteogenic tissues from the bone marrow to colonize the regenerating site.
5. By using sterile a-traumatic instruments and sterile gloves after being rinsed with sterile saline, OSSIX® PLUS and the template material are removed aseptically from the package. In order to distinguish between the membrane and the template, the template is marked with the word “TEMPLATE”.
6. OSSIX® PLUS is immersed (the inner blister can be used as a dish) for three minutes in saline, to allow for its expansion to its final dimensions (15x25 mm, 25x30 mm, 30x40 mm).
7. Trimming to the required dimensions: it is recommended that OSSIX® PLUS extends 3-4 mm beyond the margins of the defect. Therefore, the template should be trimmed respectively. One-two mm of uncovered bone to adjacent teeth must be allowed.
8. OSSIX® PLUS is cut with sterile scissors (over a sterile container) to fit the template and try-in over the defect with a-traumatic instruments should be performed.
9. The site to be augmented should be filled with a space-maintaining material. It is recommended to mix the material with blood to form a clot. It can be obtained by venous puncture or collected from the operated site. 
10. OSSIX® PLUS should be secured under the lingual flap and a bone graft placed, then the membrane carefully adapted over the defect. The membrane will adhere to the underlying tissue thus there is no need for additional membrane's fixation.
11. The muccoperiosteal flaps are sutured while ensuring that the tissue is not under tension. Do not compromise blood supply to the defect area.
12. In GTR, the use of a periodontal dressing may be considered.

The success of any surgical treatment depends on fulfilling the directions for use along with guiding the patient, as follows:
1. Preoperative patient's education regarding adequate oral hygiene, e.g.: rinsing with chlorhexidine.
2. Postoperative patient's care, e.g.:
a. Soft diet, avoidance of contact with tongue, hard food or denture.
b. Avoid contact with heat that may cause early disintegration of the collagen matrix.


1. Clinical experience with Ossix™ in the exposure area of Ossix™ membranes reveals no inflammatory signs following accidental exposure. Ossix™ is resistant to the oral environment and the exposed area is healed by connective tissue and epithelium covering the exposure within a few weeks. Therefore, if accidental dehiscence occurs with OSSIX® PLUS, the site should only be followed up, without any specific treatment.  In case of immediate flap opening, suturing with resorbable (5-0) suture is recommended.

2. Possible complications with any surgery in the oral and maxillofacial region include: infection, flap slough, perforation, abscess formation, bone loss, pain, soft tissue irregularities, and complications associated with the use of anesthesia. 

3. Depending upon the type and severity of the complications, as judged by the dental surgeon, membrane removal may be indicated.

1. OSSIX® PLUS should be used by skilled, experienced and/or trained dental surgeons.
2. The material should be handled using sterile gloves or sterile a-traumatic instruments.
3. Placement of OSSIX® PLUS should be performed after membrane's immersion in saline for 3 minutes.
4. Do not use the membrane in case that it is torn and/or damaged.
5. Do not use the membrane, in the event that the sterile packaging is opened and/or damaged.
6. Any remaining / unused membrane will be discarded according to local regulations.
7. OSSIX® PLUS should be stored at temperatures between 15-30°C (59-86°F).
8. Do not use the membrane after the expiration date.

• OSSIX® PLUS is supplied as a single membrane, double blister pack, for a single use only. The pack contains one membrane and one template.
• OSSIX® PLUS is available in 15x25 mm, 25x30 mm, 30x40 mm dimensions.
Caution: Federal (USA) law restricts this device to sale by or on the order of a licensed health care professional.

IFU Symbols
For any further assistance/support/questions, please contact the local distributor or manufacturer.
Datum Dental Ltd. 
1 Bat Sheva St. 
P.O.Box 6170
Lod 7116003 
Phone +972-8-6705400

European Authorized Representative
MedNet GmbH
Borkstrasse 10
Münster 48163
Phone +49-251-32266-0
Fax +49-251-32266-22

CE 0482
OSSIX® PLUS Instructions for Use IFU-MKT-OSP-01 ver 05, March 2016


Datum Dental Ltd is a subsidiary company of Datum Biotech. The Company was created in order to develop, manufacture and market a full line of dental biomaterials for tissue and bone regeneration.

Datum Biotech Ltd is an Israeli based Biomaterials company that specializes in developing, manufacturing and commercializing proprietary technologies, which are based on innovative and unique sugar cross-linked collagen products for tissue engineering and regenerative medicine.
read more